Magic bench McIntosh, Kyna; Mars, John; Krahe, James ...
ACM SIGGRAPH 2017 VR Village,
07/2017
Conference Proceeding
Mixed Reality (MR) and Augmented Reality (AR) create exciting opportunities to engage users in immersive experiences, resulting in natural human-computer interaction. Many MR interactions are ...generated around a first-person Point of View (POV). In these cases, the user directs to the environment, which is digitally displayed either through a head-mounted display or a handheld computing device. One drawback of such conventional AR/MR platforms is that the experience is user-specific. Moreover, these platforms require the user to wear and/or hold an expensive device, which can be cumbersome and alter interaction techniques.
We create a solution for multi-user interactions in AR/MR, where a group can share the same augmented environment with any computer generated (CG) asset and interact in a shared story sequence through a third-person POV. Our approach is to instrument the environment leaving the user unburdened of any equipment, creating a seamless walk-up-and-play experience. We demonstrate this technology in a series of vignettes featuring humanoid animals. Participants can not only see and hear these characters, they can also feel them on the bench through haptic feedback. Many of the characters also interact with users directly, either through speech or touch. In one vignette an elephant hands a participant a glowing orb. This demonstrates HCI in its simplest form: a person walks up to a computer, and the computer hands the person an object.
Pub. in Journal of AOAC International, v90 n1, p173-178, 2007.
A new competitive electrochemiluminescence-based immunoassay for the type-2 brevetoxins in oyster extracts was developed. The assay was ...verified by spiking known amounts of PbTx-3 into 80% methanol extracts of Gulf Coast oysters. We also provide preliminary data demonstrating that 100% acetone extracts, aqueous homogenates, and the clinical matrixes urine and serum can also be analyzed without significant matrix interferences. The assay offers the advantages of speed (2 h analysis time); simplicity (only 2 additions, one incubation period, and no wash steps before analysis); low limit of quantitation (conservatively, 50 pg/mL = 1 ng/g tissue equivalents); and a stable, nonradioactive label. Due to the variety of brevetoxin metabolites present and the lack of certified reference standards for liquid chromatography-mass spectrometry confirmation, a true validation of brevetoxins in shellfish extracts is not possible at this time. However, our assay correlated well with another brevetoxin immunoassay currently in use in the United States. We believe this assay could be useful as a regulatory screening tool and could support pharmacokinetic studies in animals and clinical evaluation of neurotoxic shellfish poisoning victims.
PDF